@Uber_Support Shame that this has taken this long without proper follow up! Would you kindly advise what should be the next steps to have this resolved with your driver partner!!!
@Uber_Support Shame that this has taken this long without proper follow up! Would you kindly advise what should be the next steps to have this resolved with your driver partner!!!
Inside The New Times ePaper front page of Friday, September 12, 2025: #Rwanda’s Marburg outbreak had lowest death rate, study finds
Full edition: https://t.co/W4E6QnTcej
One year later, our @NEJM study (out today) reports how science-guided detection & rapid action stopped Rwanda’s first Marburg outbreak in weeks, achieving the lowest recorded fatality
👉 https://t.co/S3YqyOJvDF
Itangazo ku mabwiriza yerekeye ishyirwa mu bikorwa ry’inyungu fatizo ku miti n’ibikoresho byifashishwa mu buvuzi.
Soma inyandiko yose hano: https://t.co/K6IdXz6FOq
———————————
Announcement on guidelines for the implementation of mark-ups for medicines and other medical products.
—————————
Communiqué sur les marges bénéficiaires appliquées aux médicaments et autres produits médicaux.
This week, I had the privilege of engaging with the incredible team at @TexasChildrens to reflect on the often invisible role of pharmacy supply chains in global health, from local manufacturing to digital systems. Grateful to Prof. @heather_haq for the kind invitation.
LONG WEEKEND ? Don’t overdo the booze 🍻🚫
Too much alcohol messes with your brain, heart & ups cancer risk.
DO BETTER: move, chill with family, learn something cool.
Ref: https://t.co/osmqW9gppL | https://t.co/dy4Ix8aCPK
#TunyweLess
The FDA just approved lenacapavir, a long-acting injectable HIV prevention medication by @GileadSciences:
• 96 to 100% protection in trials
• One injection every 6 months
But cost & rollout remain barriers
This will be a key topic at #IAS2025 Conference in Kigali,July 2025
#GileadNews: The FDA has approved our injectable HIV-1 prevention medication, making it the first and only twice-yearly #HIV prevention option in the U.S. This approval is helping to usher in the future of prevention as we work to help end the epidemic. https://t.co/wGacaduPRn
@ResearchGate Our study challenges the notion that surgery is 2 costly for RHD patients in Rwanda! Mechanical valve replacement proves to be the most cost-effective strategy, significantly improving survival and quality of life. Read more: #GlobalHealth#RHD#CostEffectiveness#CardiacSurgery
We proudly celebrate our Board members and advisors for their key role in developing Rwanda’s NAP AMR 2 (2025–2029) via the One Health TWG @RwandaHealth. Their expertise drives impactful strategies to tackle antimicrobial resistance nationally🇷🇼.#AMR#OneHealth#Pharmaceuticals
Proud to have contributed to the development of Rwanda's NAP on Antimicrobial Resistance 2025-2029! A crucial step toward safeguarding public health through a One Health approach. Excited to see the impact unfold! #AMR#OneHealth#RwandaHealth
#Rwanda's 2nd National Action Plan on Antimicrobial Resistance (NAP 2025–2029) is now in force!
✍️Formally endorsed by key ministries, NAP 2.0 launches full-scale, multisectoral action to reduce the burden of #AMR and preserve the effectiveness of antimicrobial #medicines.
📌Focus areas:
☑️Raise AMR awareness
☑️Strengthen AMR & antimicrobial use (AMU) surveillance
☑️Reduce infection rates through improved hygiene, IPC & sanitation
☑️Promote responsible antimicrobial use
☑️Invest in #AMR innovation
☑️Strengthen governance & accountability
⏭️📄 Download the press release: https://t.co/Pfk2ZuuoVV
⏭️📄 Read the full plan: https://t.co/MEW5QeUf7J
#AMR #OneHealth
@reg_rwanda we are experiencing power outage while most our neighbors have electricity. Kindly assist us in restoring power to Kimironko, Kibagabaga, Rindiro village. Who can we reach for urgent help?